S&P Global Ratings on Monday retained its forecast of 9 percent contraction in the Indian economy for the current fiscal, saying even though there are now upside risks to growth but it will wait for more signs that COVID infections have stabilised or fallen.
S&P, in its report on Asia Pacific, projected the Indian economy to grow at 10 percent in the next fiscal.
"We retain our growth forecast of negative 9 percent in fiscal 2020-2021 and 10 percent in fiscal 2021-2022. While there are now upside risks to growth due to a faster recovery in population mobility and household spending, the pandemic is not fully under control."
"We will wait for more signs that infections have stabilised or fallen, together with high-frequency activity data for the fiscal year third quarter, before changing our forecasts,” S&P said.
According to the official data released last week, Indian economy recovered faster than expected in the September quarter as a pick-up in manufacturing helped GDP clock a lower contraction of 7.5 percent.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Indian economy had contracted 23.9 percent in April-June.
The RBI in October projected India’s economy to contract by 9.5 percent this fiscal. It said the industrial sector is leading and the output is now above levels from a year ago, helped by rising demand for consumer goods.
Investment recovered faster than consumption in the second quarter, partly due to resumption of stalled projects.
The private sector drove the recovery as spending resumed and households and firms moved more toward normalised activity.
S&P said inflation should ease from recent highs, albeit gradually.
"We project that headline consumer price inflation just above the mid-point of the Reserve Bank of India’s (RBI) forecast a range of 2 to 6 percent through 2021. One-off factors should ease, including food-supply disruptions and supply constraints related to earlier lockdowns. But the pass-through to core inflation, currently near 6 per cent, suggests that inflation persistence remains a challenge,” it said.
S&P said it does not expect much fiscal easing in its projections.
"Past action has targeted low-income households, with substantial welfare effects, but a broader fiscal effort has been lacking. We do not see this changing. At the same time, the RBI will be constrained from cutting rates and we anticipate rates will start normalising upward from 2021 onwards,” it added.